☆ 4.7 Editorial Material

Advantages and Limitations of the Federal Adverse Events Reporting System in Assessing Adverse Event Reporting for Eluxadoline

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2018)

Get Full Text
Add to Collection

Journal

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY
Volume 16, Issue 3, Pages 336-338

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.cgh.2017.11.025

Keywords

-

Categories

Gastroenterology & Hepatology

Funding

  1. National Institutes of Health [R01-DK67071]

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.